SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

15d ago

SCYX

PremiumPress Releases

SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update

27d ago

SCYX

PremiumPre-Earnings

SCYX Earnings Report this Week: Is It a Buy, Ahead of Earnings?

1M ago

SCYX

PremiumPress Releases

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

3M ago

SCYX

PremiumPress Releases

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

3M ago

SCYX

PremiumPress Releases

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

4M ago

SCYX

PremiumPress Releases

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

5M ago

SCYX

More SCYX News >

SCYX News on the Web

2024-04-11

Buy Rating Affirmed for SCYNEXIS on Strong Financials and Promising Pipeline Prospects

TipRanks News

Bullish

2024-04-09

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases

Yahoo Finance

Neutral

2024-03-29

SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023

InvestorPlace

Neutral

2024-03-28

SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update

Yahoo Finance

Neutral

2024-01-30

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

Yahoo Finance

Neutral

2024-01-29

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

Yahoo Finance

Neutral

2024-01-05

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

Yahoo Finance

Neutral

2024-01-04

Should You Buy SCYNEXIS Inc (SCYX) Stock Thursday Morning?

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SCYX’s Media Buzz Sentiment?

Currently, no data Available

What is SCYX’s weekly average amount of articles?

Currently, no data Available

What is SCYX’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

ELVElevance Health

CGEMCullinan Management

MRNSMarinus

EWEdwards Lifesciences

INSPInspire Medical Systems

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing